3 Stocks to Sell as Ozempic Surges in Popularity

Novo Nordisk’s (NYSE:NVO) Ozempic diabetes treatment, marketed as a weight loss treatment under the Wegovy brand name, has become the latest mega-blockbuster drug. Yet, while you may be thinking about ways to capitalize on its popularity and the rise of other glucagon-like peptide-1 (GLP-1) weight loss treatments, you should also consider the stocks to sell because of this trend.Eli Lilly (NYSE:LLY) may be poised to give Novo Nordisk a run for its money, with its similar offering Mounjaro, marketed to treat ...